Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | SCN1A | P35498 | 1/20 | 0.33 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.33 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ANPEP | P15144 | 1/20 | 0.32 |
| ▸ | CETP | P11597 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20436302 | 0.78 | SMN1; SMN2 (0.49) | ALDH1A1MAPTMAPK1PGRSCN1A | |
| SCHEMBL20421656 | 0.73 | ALDH1A1 (0.50) | ALDH1A1MAPTHSD17B10MAPK1SCN3A | |
| SCHEMBL3745454 | 0.67 | ALDH1A1 (0.49) | ALDH1A1MAPTPOLBLMNAGAA | |
| SCHEMBL20436310 | 0.65 | NLRP3 (0.36) | ALDH1A1MAPTHSD17B10MAPK1HPGD | |
| SCHEMBL20436308 | 0.63 | ITGB3 (0.64) | ALDH1A1MAPK1GAAL3MBTL1 | |
| SCHEMBL20436303 | 0.63 | MGLL (0.46) | ALDH1A1MAPTHPGDGAAL3MBTL1 | |
| SCHEMBL8580626 | 0.62 | ACE (0.42) | ACEALDH1A1 | |
| SCHEMBL9623845 | 0.62 | ACE (0.42) | ACEALDH1A1 | |
| SCHEMBL16559111 | 0.62 | KDM4E (0.40) | ALDH1A1HSD17B10PGRHPGDLMNA | |
| SCHEMBL12989759 | 0.60 | ACE (0.48) | ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180217113-A1 | METHOD FOR ANALYZING ENANTIOMER | AJINOMOTO CO., INC. (JP) | 2018-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180217113-A1 | METHOD FOR ANALYZING ENANTIOMER | DCX, INF2, SRD5A2 | ACE 580/4885CNR2 1176/4885ALDH1A1 834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.